N@N

Optimer Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference

_{//health-fitness.news-articles.net/content/2008/ .. 7th-annual-j-p-morgan-healthcare-conference.html}
^{Published in Health and Fitness on Wednesday, December 17th 2008 at 7:24 GMT by Market Wire}  

SAN DIEGO--([ BUSINESS WIRE ])--Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) is scheduled to present at the 27^th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on January 13, 2009, 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time). Michael N. Chang, Optimer's President and Chief Executive Officer, is scheduled to provide an overview of the company and its clinical development program.

A live audio webcast of this presentation will be accessible on the Company's website at [ www.optimerpharma.com ], under the investors section. A replay of this presentation will be available at the same location for thirty days following the meeting.

About Optimer Pharmaceuticals

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. OPT-80 is the only antibiotic therapy currently under Phase 3 worldwide development for Clostridium difficile infection. Prulifloxacin is an antibiotic being developed for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at http://[ www.optimerpharma.com ].